1. Hepatic Involvement in Systemic Sarcoidosis.
- Author
-
Ibrahim AM, Bhandari B, Soriano PK, Quader Z, Gao JZ, Shuster D, and Mamillapalli CK
- Subjects
- Aged, Biopsy, Diagnosis, Differential, Female, Glucocorticoids therapeutic use, Humans, Liver Diseases drug therapy, Liver Diseases etiology, Magnetic Resonance Imaging, Prednisone therapeutic use, Sarcoidosis diagnosis, Sarcoidosis drug therapy, Liver pathology, Liver Diseases diagnosis, Sarcoidosis complications
- Abstract
BACKGROUND Sarcoidosis is a systemic disease that can affect any organ, including the liver. It is manifested by the presence of non-caseating granulomas within involved organs, most commonly the pulmonary, lymphatic, and hepatic system. Unlike pulmonary or lymphatic involvement, hepatic involvement is usually asymptomatic and it is underdiagnosed. Here, we report a case of a patient with a history of pulmonary sarcoidosis who developed hepatic sarcoidosis. CASE REPORT 68-year-old female with pulmonary sarcoidosis with a 2-week history of severe abdominal pain and epigastric tenderness presented to our center. Abdominal magnetic resonance imaging (MRI) demonstrated mild hepatic fibrosis and cirrhosis. A thorough workup was performed including a liver biopsy which showed chronic non-necrotizing granulomas consistent with sarcoidosis. She was started on prednisone and subsequently improved. The patient was symptom-free on follow-up 1 month later. CONCLUSIONS The majority of patients with hepatic sarcoidosis are usually asymptomatic, with only 5-30% presenting with abdominal pain, jaundice, nausea, vomiting, and hepatosplenomegaly. In rare cases, hepatic sarcoidosis can lead to cholestasis, portal hypertension, cirrhosis, or Budd-Chiari syndrome. Treatment with steroids is the mainstay of therapy; however, in severe cases, patients may require liver transplantation. This case report demonstrates that hepatic sarcoidosis is a serious condition, and if not treated, can lead to portal hypertension and cirrhosis. In patients with sarcoidosis, early detection and longitudinal follow-up is important in preventing overt liver failure.
- Published
- 2018
- Full Text
- View/download PDF